Prostate Cancer Trial, Recruiting NCT06500169 Sponsor: University of Southern California Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06500169
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with prostate cancer for the first time (not a recurring or second diagnosis)
  • People who have been receiving hormone therapy (to reduce testosterone) and/or hormone-blocking medication for more than 6 months
  • Men aged between 55 and 85 years old
  • People who are able to stand up on their own without needing help or support
  • People with little to no golf experience (played fewer than 5 times in the last 10 years)
  • People who speak English

Who may not be able to join:

  • People who have been diagnosed with a second type of cancer (not including minor, non-invasive skin cancers), or whose prostate cancer has spread to the bones
  • People who had their prostate surgically removed less than 6 months before joining the study (note: having had this surgery is not required to participate)
  • People with active or poorly controlled heart conditions, including chest pain (angina), high blood pressure above certain levels, a resting heart rate above 90 beats per minute, or dizziness caused by changes in blood pressure when standing
  • People with unstable or recently worsened asthma or chronic lung disease (COPD)
  • People who have had an injury or bone/joint surgery in the last 6 months
  • People with movement or neurological disorders such as Parkinson's disease, or conditions affecting movement on one or both sides of the body
  • People with severe vision or hearing difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: George Salem, PhD, University of Southern California

Phone: (323)442-3113

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Enrollment rate; Participant adherence to the program; Cost of the program; Staff adherence; Program accommodations; Incidence of adverse events; Quality of life scores; Circulating inflammatory biomarker levels; Senior fitness test scores; Gait speed; Balance Confidence; Cognitive function; Participant feedback of the program

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov